Previous 10 | Next 10 |
2023-04-27 09:45:00 ET If you have $20,000 or more in savings that you can afford to invest in stocks, you may want to consider putting that in some high-yielding investments that can provide you with some great recurring income. Viatris (NASDAQ: VTRS) and AT&T (NYSE: ...
Viatris and Mapi Pharma to Highlight Latest Results of Multiple Sclerosis Research at American Academy of Neurology 75th Annual Meeting PR Newswire Meeting program to feature latest clinical findings for GA Depot and showcase commitment to improving care for people living with...
2023-04-23 12:00:00 ET Biotech deal-making is on a roll, with more than $12B worth of transactions announced over the past week alone, and, according to industry observers, the trend is expected to continue in 2023, supported by macro and certain industry-specific factors. Days after Me...
2023-04-18 22:30:00 ET Summary Miller Value Partners is a value investor. It values businesses, and not just stocks, and invests in them for the long term. The Miller Income Strategy‘s representative account returned -3.51% net of fees versus 3.72% for the ICE Bank of Ameri...
2023-04-18 02:32:00 ET Summary Not only do most companies pay dividends in the third month of the quarter, mutual funds and ETFs do as well. We received $5,299.66 in March dividend income. This was a 6.93% dividend increase compared to March 2022. We received over half our inc...
2023-04-17 10:48:07 ET The U.S. Supreme Court on Monday declined to hear a case filed by Sanofi ( NASDAQ: SNY ) to revive an antitrust lawsuit that charged Viatris ( NASDAQ: VTRS ) of illegally monopolizing the U.S. market for the Epinephrine auto-injectors. The justices...
2023-04-16 04:01:11 ET Summary Viatris is a spin-out of generics drug giant Mylan and Pfizer's legacy brands division UpJohn. Spinouts are a tough business to make a bull case for - if the spun-out assets were winners, they would not have been divested. Viatris began life sadd...
Viatris to Report First Quarter 2023 Financial Results on May 8, 2023 PR Newswire PITTSBURGH , April 12, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to report its first quarter 2023 financial results on Monday, May 8 before the open of the...
2023-04-12 00:11:00 ET Summary The system is clearly broken, and has been for a while; however, I could find comfort in one thing, my dividends. Four figures in a month is a win in my book. Earning $1,893.81 represents 12.6% year over year increase in passive income. With pati...
NCD Academy Launches New Health Equity and Social Determinants of Health Course PR Newswire Innovative online education platform helping global healthcare professionals address non-communicable diseases PITTSBURGH and WASHINGTON , April 6, 2023 /PRNew...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 12:25:00 ET The late comedian Rodney Dangerfield was famous for his catchphrase, "I don't get no respect." Does Dangerfield's line apply to some stocks today? Absolutely. Three Motley Fool contributors think they've found surprisingly underrated pharmaceutical stocks to b...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...